EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Role of Hypoxia-Sensitive miRNA181a, miRNA199a, SIRT1, and Adiponectin in Diabetes Mellitus Type 2 Development in Obstructive Sleep Apnea Patients

Filip Franciszek Karuga iD, Piotr Kaczmarski, Marcin Sochal iD, Bartosz Szmyd, Greta Veronika Urbonaitė, Szymon Turkiewicz, Piotr Białasiewicz, Agata Gabryelska iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26199699 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Filip Franciszek Karuga und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Sleep Medicine and Metabolic Disorders, Medical University of Lodz, 90-419 Lodz, Poland. Hauptthemen laut MEDLINE: Sirtuin 1, MicroRNAs, Sleep Apnea, Obstructive, Diabetes Mellitus, Type 2. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Centre.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Obstructive sleep apnea (OSA) is a chronic respiratory disorder characterized by intermittent hypoxia and is strongly associated with the development of type 2 diabetes mellitus (T2DM). Despite this link, the molecular mechanisms underlying OSA-related metabolic dysregulation remain incompletely understood. The aim of the study was to investigate the role of hypoxia-sensitive microRNAs, sirtuin 1 (SIRT1), and adiponectin in the metabolic profile of OSA patients, with and without T2DM. A total of 87 participants were stratified into three groups: OSA, OSA + T2DM, and healthy controls. Blood samples were collected in the evening and morning, and after continuous positive airway pressure (CPAP) therapy. Expression levels of miRNAs and SIRT1 were measured via RT-qPCR; adiponectin was quantified by ELISA. Significantly reduced expression of miRNA-181a and miRNA-199a was observed in the OSA + T2DM group compared to OSA (p = 0.035 and p = 0.042, respectively). In contrast, SIRT1 expression was highest in the OSA + T2DM group (p < 0.01), while adiponectin concentrations was lowest in this group and the highest among healthy controls (p = 0.001). Despite increased SIRT1 in OSA + T2DM patients, the parallel increase in adiponectin was not observed. Additionally, expression of SIRT1 was significantly increased in OSA patients who were taking metformin (n = 23) vs. patients without metformin (n = 32) 77.315 vs. 437.08 (p = 0.037). CPAP therapy had significant influence only on miRNA-181a—expression was increased after long-term treatment (p = 0.047). Increased miRNA-181a expression in patients with OSA is related to decreased SIRT1 expression, which may lead to T2DM development. Surprisingly, the expression of SIRT1 is significantly higher and expression of hypoxia-sensitive miRNAs is significantly lower in patients with already developed T2DM, which might be explained by metformin intake.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sirtuin 1MicroRNAsSleep Apnea, ObstructiveDiabetes Mellitus, Type 2AdiponectinHypoxiaHumansMaleMiddle AgedFemaleAdultContinuous Positive Airway PressureCase-Control Studies

Stichwörter der Autor:innen

OSAadiponectinepigeneticshypoxiametforminmicroRNAssirtuinsleep

Substanzen

Sirtuin 1MicroRNAsAdiponectinSIRT1 protein, humanmirn199 microRNA, humanMIrn181 microRNA, humanADIPOQ protein, human

Autor:innen und Institutionen

  • Department of Sleep Medicine and Metabolic Disorders, Medical University of Lodz, 90-419 Lodz, Poland.
  • Department of Neurosurgery and Neuro-Oncology, Barlicki University Hospital, Medical University of Lodz, 90-419 Lodz, Poland.
  • Department of Pediatrics, Oncology, and Hematology, Medical University of Lodz, 90-419 Lodz, Poland.
  • Clinical Department of Radiotherapy, Radom Oncology Center, 26-600 Radom, Poland.

ORCID-Profile: Filip Franciszek Karuga, Marcin Sochal, Agata Gabryelska

Förderung

  • National Science Centre

Zitieren

APA

Karuga, F. F., Kaczmarski, P., Sochal, M., Szmyd, B., Urbonaitė, G. V., Turkiewicz, S., Białasiewicz, P., & Gabryelska, A. (2025). The Role of Hypoxia-Sensitive miRNA181a, miRNA199a, SIRT1, and Adiponectin in Diabetes Mellitus Type 2 Development in Obstructive Sleep Apnea Patients. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26199699

Vancouver

Karuga FF, Kaczmarski P, Sochal M, Szmyd B, Urbonaitė GV, Turkiewicz S, et al. The Role of Hypoxia-Sensitive miRNA181a, miRNA199a, SIRT1, and Adiponectin in Diabetes Mellitus Type 2 Development in Obstructive Sleep Apnea Patients. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26199699

BibTeX
@article{Karuga2025,
  author = {Karuga, Filip Franciszek and Kaczmarski, Piotr and Sochal, Marcin and Szmyd, Bartosz and Urbonaitė, Greta Veronika and Turkiewicz, Szymon and Białasiewicz, Piotr and Gabryelska, Agata},
  title = {The Role of Hypoxia-Sensitive miRNA181a, miRNA199a, SIRT1, and Adiponectin in Diabetes Mellitus Type 2 Development in Obstructive Sleep Apnea Patients},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26199699}
}
Kostenlos starten →